50 related articles for article (PubMed ID: 38461408)
1. Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.
Tavaglione F; Flagiello V; Terracciani F; Gallo P; Capparelli E; Spiezia C; De Vincentis A; Palermo A; Scriccia S; Galati G; Napoli N; Daniels SJ; Blau JE; Carlsson B; Khazrai YM; Incalzi RA; Picardi A; Vespasiani-Gentilucci U
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3787. PubMed ID: 38461408
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-Derived Fat Fraction for Hepatic Steatosis Assessment: Prospective Study of Agreement With MRI PDFF and Sources of Variability in a Heterogeneous Population.
Kubale R; Schneider G; Lessenich CPN; Buecker A; Wassenberg S; Torres G; Gurung A; Hall T; Labyed Y
AJR Am J Roentgenol; 2024 Jun; ():1-13. PubMed ID: 38506537
[No Abstract] [Full Text] [Related]
3. Usefulness of health checkup-based indices in identifying metabolic dysfunction-associated steatotic liver disease.
Miwa T; Tajirika S; Imamura N; Adachi M; Horita R; Hanai T; Ng CH; Siddiqui MS; Fukao T; Shimizu M; Yamamoto M
JGH Open; 2024 Jun; 8(6):e13110. PubMed ID: 38895100
[TBL] [Abstract][Full Text] [Related]
4. Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease.
Wang SW; Hsieh TH; Cheng YM; Wang CC; Kao JH
Hepatol Int; 2024 Jun; 18(3):943-951. PubMed ID: 38227142
[TBL] [Abstract][Full Text] [Related]
5. Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease.
Yin H; Fan Y; Yu J; Xiong B; Zhou B; Sun Y; Wang L; Zhu Y; Xu H
Insights Imaging; 2024 Jun; 15(1):159. PubMed ID: 38902550
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and non-invasive assessment of MASLD in type 2 diabetes and obesity.
Chan WK; Petta S; Noureddin M; Goh GBB; Wong VW
Aliment Pharmacol Ther; 2024 Jun; 59 Suppl 1():S23-S40. PubMed ID: 38813831
[TBL] [Abstract][Full Text] [Related]
7. Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trial.
Stefan N; Hartleb M; Popovic B; Varona R
Trials; 2024 Jun; 25(1):374. PubMed ID: 38858768
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options.
Portincasa P; Khalil M; Mahdi L; Perniola V; Idone V; Graziani A; Baffy G; Di Ciaula A
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891828
[TBL] [Abstract][Full Text] [Related]
9. Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study.
Mayén AL; Sabra M; Aglago EK; Perlemuter G; Voican C; Ramos I; Debras C; Blanco J; Viallon V; Ferrari P; Olsen A; Tjønneland A; Langmann F; Dahm CC; Rothwell J; Laouali N; Marques C; Schulze MB; Katzke V; Kaaks R; Palli D; Macciotta A; Panico S; Tumino R; Agnoli C; Farràs M; Molina-Montes E; Amiano P; Chirlaque MD; Castilla J; Werner M; Bodén S; Heath AK; Tsilidis K; Aune D; Weiderpass E; Freisling H; Gunter MJ; Jenab M
BMC Med; 2024 Jun; 22(1):221. PubMed ID: 38825687
[TBL] [Abstract][Full Text] [Related]
10. Genetic correlations between liver fat content, metabolic health, and adiposity distribution in the Fels Longitudinal Study.
Garza AL; Lee M; Blangero J; Bauer CX; Czerwinski SA; Choh AC
Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1610-1618. PubMed ID: 38555241
[TBL] [Abstract][Full Text] [Related]
11. Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention.
Tobaruela-Resola AL; Riezu-Boj JI; Milagro FI; Mogna-Pelaez P; Herrero JI; Elorz M; Benito-Boillos A; Tur JA; Martínez JA; Abete I; Zulet MA
Nutrients; 2024 May; 16(11):. PubMed ID: 38892481
[TBL] [Abstract][Full Text] [Related]
12. Metabolic dysfunction-associated fatty liver disease and low muscle strength: A comment.
Karim MM; Butt AS
World J Gastroenterol; 2024 May; 30(17):2371-2373. PubMed ID: 38813051
[TBL] [Abstract][Full Text] [Related]
13. A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study.
Long MT; Pedley A; Massaro JM; Hoffmann U; Ma J; Loomba R; Chung RT; Benjamin EJ
Liver Int; 2018 Aug; 38(8):1495-1503. PubMed ID: 29377504
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound backscatter coefficient for fat quantification is affected by the measurement depth.
Ferraioli G; De Silvestri A; Torres G; Barr RG
Abdom Radiol (NY); 2024 Jun; ():. PubMed ID: 38834778
[TBL] [Abstract][Full Text] [Related]
15. WFUMB Guidelines/Guidance on Liver Multiparametric Ultrasound. Part 2: Guidance on Liver Fat Quantification.
Ferraioli G; Barr RG; Berzigotti A; Sporea I; Wong VW; Reiberger T; Karlas T; Thiele M; Cardoso AC; Ayonrinde OT; Castera L; Dietrich CF; Iijima H; Lee DH; Kemp W; Oliveira CP; Sarin SK
Ultrasound Med Biol; 2024 Aug; 50(8):1088-1098. PubMed ID: 38658207
[TBL] [Abstract][Full Text] [Related]
16. EMC10 modulates hepatic ER stress and steatosis in an isoform-specific manner.
Chen K; Wang Y; Yang J; Klöting N; Liu C; Dai J; Jin S; Chen L; Liu S; Liu Y; Yu Y; Liu X; Miao Q; Liew CW; Wang Y; Dietrich A; Blüher M; Wang X
J Hepatol; 2024 Apr; ():. PubMed ID: 38599383
[TBL] [Abstract][Full Text] [Related]
17. Review article: Hepatic steatosis and its associations with acute and chronic liver diseases.
Koenig AB; Tan A; Abdelaal H; Monge F; Younossi ZM; Goodman ZD
Aliment Pharmacol Ther; 2024 Jun; ():. PubMed ID: 38845486
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD46 as a diagnostic marker of hepatic steatosis.
Bitterer F; Kupke P; Adenugba A; Evert K; Glehr G; Riquelme P; Scheibert L; Preverin G; Böhm C; Hornung M; Schlitt HJ; Wenzel JJ; Geissler EK; Safinia N; Hutchinson JA; Werner JM
EBioMedicine; 2024 Jun; 104():105184. PubMed ID: 38838471
[TBL] [Abstract][Full Text] [Related]
19. Simulating federated learning for steatosis detection using ultrasound images.
Qi Y; Vianna P; Cadrin-Chênevert A; Blanchet K; Montagnon E; Belilovsky E; Wolf G; Mullie LA; Cloutier G; Chassé M; Tang A
Sci Rep; 2024 Jun; 14(1):13253. PubMed ID: 38858500
[TBL] [Abstract][Full Text] [Related]
20. Investigating peripheral blood monocyte and T-cell subsets as non-invasive biomarkers for asymptomatic hepatic steatosis: results from the Multi-Ethnic Study of Atherosclerosis.
Niedecker RW; Delaney JA; Doyle MF; Sparks AD; Sitlani CM; Buzkova P; Zeb I; Tracy RP; Psaty BM; Budoff MJ; Olson NC
Front Immunol; 2024; 15():1243526. PubMed ID: 38596669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
